Cite
HARVARD Citation
Garrelfs, S. et al. (n.d.). LB002ILLUMINATE-A, A PHASE 3 STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN CHILDREN AND ADULTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1). Nephrology dialysis transplantation. p. . [Online].